New members in Oslo Medtech
We congratulate the nine new members who was approved by the board of Oslo Medtech, February 9th.
More than 80 companies and organizations are now members of Oslo Medtech.
The newest members are:
Upcoming events
Oslo Medtech February, March and April 2011
February 17th: Oslo Medtech Breakfastmeeting at the Intervention Centre, Oslo University Hospital - Rikshospitalet.
Program:
 |
|
- Intervention Centre as a 'testbed' and arena for testing and verification of new methods, products and solutions:
Professor Erik Fosse, Direktor at the Intervention Centre, will present the Intervention Centre and give us a live tour in the surgical theatre.
|
| |
|
- Possibilities and options in the cooperation between research and industry.
Presentation by CEO Jostein Dalland, Inven2 AS
|
| |
|
- How to succeed with the productdevelopment - and the necessity of good partners. Presentation by CEO Geir Christian Melen, Ostomycure AS
|
March 1st: QA-Reg meeting; QA-Reg guidelines for entrepreneurs, Det Norske Veritas. Time: 13-16.
March 31st: Oslo Medtech Breakfastmeeting – Service providers
April 4th: Medtech Market Insight - USA
April 5th: Medtech Market Insigt - USA - one-to-one meetings
External upcoming events to look out for
MedITnor arranges a Charity Technology Conference 2011 (Velferdskonferansen 2011). Rica Hell Hotel, 8 to 9 June 2011. MedITnor want your contribution to this conference and open for proposals for presentations or themes from anyone who is interested in the welfare technology. Read more at MedITnor and www.velferdsteknologikonferansen.no
Norwegian Industrial Property Office (Patentstyret) invites to seminar on
Patent protection ABC Part 1; Why, how and what can be patented? March 2nd, 09:00 – 16:30. Read more.
Norsk Biotekforum invites to “Brennpunkt IPR” Thursday March 10th, 12.30 – 16.00. Read more
The Research Council of Norway (Norges Forskningsråd) holds two meetings on EU 7Rp.
“EUs FP7, Information seminar on advertisements 2012”. A grand, national information meeting May 3rd, 09:30 – 15:30.
"How to Write a Competitive Proposal for Framework 7"; A full day course which aims to train potensial application writers to formulate professional and competitive applications to EUs FP7. The course describes common problems and provides tips on how to gather information, choose strategic partners and how to avoid double work.
News from Oslo Medtech Members
Regional Research Fund
- The capital grant pilot funding for several projects involving Oslo MedTech members
Oslo MedTech congratulates Otivio AS, Novelda AS, Bakteriefritt AS, SINTEF, Abilia AS, Imatis AS, Help 24 AS and Geria with good applications and public utility project focus. The constructive partnerships between business, research and health institutions will help reduce the challenges in the health sector.
The companies has been granted funding from the Regional Research Fund - Hovedstadens announcement related to "Community needs for health care services and technology for the aging population".
Read more (link to norwegian article)
Investment opportunity in PubGene Inc.
PubGene has reached the milestone of developing Coremine Medical and the Coremine Platform. To further scale the business according to the planned business strategy for market entry and scaling, the company has decided to increase the equity capital through a share issue to private investors. “We want to establish a broad ownership community in PubGene where share owners can closely follow, and in some cases contribute in the scaling of Coremine on the international market”, it says in a statement from the company. Read more
SFI status awarded to "Centre of Cardiological Innovation"
The project involves several Oslo Medtech members; the host Oslo University Hospital has Simula Research Laboratory as research partner and GE Vingmed Ultrasound AS, CardioSolv LLC, Biosense Webster Ltd and Kalkulo AS as company partners. The Centre for Cardiological Innovation aims to be a world leader in research on ultrasound-based diagnosis.
Read more
FDA clearance and ten approved patents for dPCom AS
 dPCom received FDA clearance in November 2010 for its software, Sensometrics ® Software. Sensometrics ® Software meets the strict requirements for products applied in the health sector in the United States. dPCom is in a unique position after receiving FDA clearance, CE certification, 10 approved patents and proof of concept through many clinical studies.
Read more
MediStim announces that they started up direct sales representation in Denmark
The distribution agreement with In-Vivo Aps has been terminated and MediStim is in process of recruiting for a direct sales organization in Denmark.
Read more
Oslo Medtech News
Quality Assessment Regulatory (QA-Reg) Forum - Building step-by-step knowledge for entrepreneurs
 Oslo Medtech has brought the experts in the QA-REG field closer to you. By setting up seminars and building documentation, we invite members of Oslo Medtech to enhance their knowlede, step-by-step, of the importance of quality- and regulatory requirements, classification and approval procedures in different markets/continents. We hope to build enthusiasm and acknowledge for that regulatory issues is an important part of the companies strategy – business plan as well as financial plan.
The QA-Reg forum was initiated by Oslo Medtech and the cooperating partners Nemko, Haflan Resources and Det Norske Veritas (DNV) in the spring of 2010. The aim is to contribute to increase the companies’ knowledge and competence on regulatory issues in different markets. The forum is also a central network arena for members of Oslo Medtech, where present QA- and regulatory issues will be presented and discussed.
In progress is the development of a QA-Reg Guideline for Entrepreneurs, which will be released at the Oslo Medtech website. Information is continuously shared at www.oslomedtech.no, open to all interested partners. However, Oslo Medtech is now setting up members pages, where even more valuable knowledge is to be shared with and among members only. These pages will be available for Oslo Medtech members by using and personal password and a member-login procedure.
The picture is of Schmidbauer, General Manager, Nemko USA, Inc. and
leader of Nemko CoE for medical devices, taken at Oslo Medtech QA-Reg forum January 25th “Market access for medtech products for North America”.
 Further focus on information and communication in Oslo Medtech
Cecilie Nordbø has been appointed as a new employee in Oslo Medtech, focusing on information, marketing, events and membership services. "It is a pleasure to welcome Cecilie to Oslo Medtech. The expansion of the administration is of great value for Oslo Medtech and its members, and is a result of the additional financial support from Innovation Norway Oslo, Akershus, Østfold and the ARENA programme for 2011", says CEO, Kathrine Myhre.
Cecilie earns a masters degree in Science, Society & Technology from University / Universite Louis Pasteur, Strasbourg and has experience from the field of customer relationship management (CRM) and market communications in the IT and telecom industry. She comes from a position at Forskningsparken - Oslo Innovation Center.
 Tone Yrvum appointed as the CEO of Oslo Cancer Cluster
Tone Yrvum (42) has been appointed as the new CEO of Oslo Cancer Cluster and will enter the position in May this year. She comes from a position as sales and marketing director at Mole Genetics, a biotechnology company where she is one of the founders.
Calls
Investment meeting
The Oslo Medtech member PubGene, invites to investment meeting on Tuesday February 15th, 11:00 AM. The company and Coremine Medical will be presented. Please send an email to Eirik Næss-Ulseth, eirik@pubgene.com, to confirm your participation at the meeting. Read more
Electronics Price seeks candidates
On 8 of June 2011, Vebjørn Tandberg Electronics Prize will be awarded for the sixth time. It is now open for registration of candidates for the award to promote innovation from companies in stage of market development. Registration date is April 14th.
Candidates may apply by this link.
 Participate in the competition for the 1 million NOK!
DnB NOR's Innovation Award 2011 is now announced, and the deadline for participation is February 28th. The competition 2010 was won by Protia. The Peoples Award went to the Oslo Medtech member Ostomycure, who also won 3rd place in the Innovation Award. Registration date is February 28th.
Read more
Membership in Oslo Medtech
Do you, your company or institution want to become a member of Oslo Medtech?
Arena is a national program owned by Forskningsrådet, SIVA and Innovation Norway.
|